Peringkat dalam Saham
#18608
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Harga Saham
$0.88044964
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$192.54M
Perubahan (1 hari)
-0.71%
Perubahan (1 tahun)
1,362.12%
Perdagangan Circio Holding ASA (CRNA)
Harga CRNA dengan kapitalisasi pasar B
Kapitalisasi pasar dari Circio Holding ASA(CRNA)
Kapitalisasi Pasar: $192.54M
Per August 2026, Circio Holding ASA memiliki kapitalisasi pasar sebesar $192.54M. Ini menjadikan Circio Holding ASA sebagai perusahaan 18608th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Circio Holding ASA dari 2016 hingga 2026
CRNA dibandingkan dengan 5 teratas stocks paling populer
| Harga CRNA |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.088T
|
+2,642,458.94%
|
|
|
|
|
$4.629T
|
+2,404,177.67%
|
|
|
|
|
$4.113T
|
+2,136,087.20%
|
|
|
|
|
$3.687T
|
+1,914,721.92%
|
|
|
|
|
$2.800T
|
+1,453,992.01%
|
